BTG Acquires Roxwood Medical


October 5, 2017—BTG plc announced it has acquired Roxwood Medical, a provider of advanced cardiovascular specialty catheters used in treating patients with severe coronary and peripheral artery disease. BTG stated that Roxwood's products complement its existing business and will be offered through BTG's existing Ekos hospital sales force.

According to BTG, Roxwood's anchoring catheters (CenterCross, CenterCross Ultra, MultiCross) and microcatheters (MicroCross) offer options for physicians in crossing complex lesions and arterial blockages. Roxwood's catheters incorporate a self-expanding scaffold that stabilizes the delivery of a guidewire. The devices provide positioning accuracy and support to facilitate the crossing of blockages, mitigating guidewire buckling, and enabling treatments such as angioplasty, stenting, or atherectomy.

BTG advised that it will pay up to $80 million in cash to acquire Roxwood, which includes $65 million paid on closing and up to an additional $15 million upon achievement of certain future commercial milestones.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.